Successful treatment of D-penicillamine-induced breast gigantism with danazol

P J Taylor, P Taylor, David C. Cumming, D C Cumming, B Corenblum, Bernard Corenblum
British medical journal (Clinical research ed.) · 1981 · vol. 282(6261) , pp. 362.2–363 · doi:10.1136/bmj.282.6261.362-a · PMID:6780026 · PMC1504185 · W1971433971
Case report OA: bronze CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-27 ⓘ

A controlled trial found a new tablet preparation of De-Nol to be as effective as the established liquid formulation for treating duodenal ulcers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Controlled trial comparing De-Nol tablets with De-Nol liquid in treatment of duodenal ulcer De-Nol (tri-potassium di-citrato bismuthate) is effective in the treatment of duodenal ulcer,' but its usefulness is limited by the unpleasant taste and smell of the liquid formulation.We compared the effectiveness of a new tablet preparation of De-Nol with the established liquid preparation in the treatment of duodenal ulcer.

My notes (saved in your browser only)

MeSH descriptors

Breast Breast Diseases Danazol Penicillamine Pregnadienes Adult Arthritis, Rheumatoid Arthritis, Rheumatoid Breast Breast Diseases Breast Diseases Danazol Estradiol Estradiol Female Humans Hypertrophy Hypertrophy Hypertrophy Penicillamine

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (5)

Source provenance

openalex
last seen: 2026-05-11T05:08:34.710727+00:00
pubmed
last seen: 2026-10-08T21:58:26.348914+00:00
License: CC0 · commercial use OK